This is the information currently posted on the the clinical trails gov website regarding their diabetic foot ulcer study. Hopefully we'll get an update in the near future.
Study Type: Interventional (Clinical Trial) 1 EstimatedEnrollment: 138 participants 2 Allocation: Randomized 3 Intervention Model: Parallel Assignment 4 Masking: None (Open Label) 5 Primary Purpose: Treatment 6 Official Title: A Prospective, Multicenter, Open Label, Randomized, Controlled Clinical Study Evaluating the Effect of NovoSorb ® SynPath™ Dermal Matrix Compared to Standard of Care (SOC) In the Treatment of Nonresponsive, Chronic Diabetic Foot Ulcers. 7 ActualStudy Start Date: July 10, 2022 8 EstimatedPrimary Completion Date: December 1, 2023 9 EstimatedStudy Completion Date: March 1, 2024
- Forums
- ASX - By Stock
- PNV
- PNV - Banter and General Comments
PNV
polynovo limited
Add to My Watchlist
3.17%
!
$1.22

PNV - Banter and General Comments, page-10865
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.22 |
Change
-0.040(3.17%) |
Mkt cap ! $849.7M |
Open | High | Low | Value | Volume |
$1.25 | $1.25 | $1.22 | $221.8K | 178.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 28513 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 8716 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 12056 | 1.225 |
10 | 30642 | 1.220 |
11 | 47989 | 1.215 |
10 | 86781 | 1.210 |
6 | 155385 | 1.205 |
Price($) | Vol. | No. |
---|---|---|
1.230 | 5558 | 11 |
1.235 | 14520 | 9 |
1.240 | 13584 | 10 |
1.245 | 30527 | 12 |
1.250 | 59860 | 11 |
Last trade - 11.14am 21/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |